Similar Articles |
|
Fast Company February 2004 Bill Breen |
The Cannabis Conundrum As the founder of a British pharmaceutical company puts it, if it weren't called marijuana there would be an entire biotech business built around this plant. And that's just what's starting to happen (but not for the U.S. drug industry or the American patients these medicines might help). |
Fast Company Alex Halperin |
The California-Colorado Cannabis War While California is the largest addressable cannabis market in the USA, the risks associated with setting up there outweighed the benefits. |
Fast Company February 2004 |
Pot Proponent Just Says No Medical marijuana's elder statesman is not convinced that the therapeutic benefits of cannabis can be separated from the psychoactive effects -- or that cannabis should be "pharmaceuticalized." |
Fast Company February 2004 Bill Breen |
Dr. Dope's Connection David Watson, the CEO of the Dutch pharmaceutical R&D company Hortapharm, has assembled what is arguably the world's most comprehensive cannabis-seed library. |
Fast Company February 2004 Bill Breen |
Pipe Dream? Rick Doblin has a prescription for fixing NIDA's ailing medical-marijuana program: establish an alternative. |
Chemistry World February 17, 2015 Rebecca Trager |
Clinical trials high on list for medical marijuana community The drug's controlled status is continuing to slow efforts to investigate the myriad compounds in the plant. |
Salon.com August 31, 2000 David Tuller |
Striking down medical marijuana San Francisco's pro-pot district attorney discusses the long-term implications of the Supreme Court's ruling. |
Reason February 2007 Greg Beato |
Pot Clubs in Peril Are San Francisco zoning boards a bigger threat to medical marijuana than the DEA? |
Salon.com July 19, 2000 Colin Moynihan |
Pot shots Two hot marijuana magazines are threatening High Times' hemp hegemony. |
Chemistry World February 3, 2015 |
High hopes The multi-target, rebalancing properties of cannabinoids also explains why they show promise as drugs in such a wide variety of conditions. |
Reason Aug/Sep 2009 Brian Doherty |
Weed Control: Feds make bad dealers Marijuana research in the United States is dominated by a lone, big-muscled monopolist: the federal government. |
Chemistry World May 15, 2009 Katrina Megget |
Tripping over red tape The UK may be moving a step closer to allowing the use of a cannabis-based drug to treat the symptoms of multiple sclerosis |
Salon.com January 5, 2001 Daniel Forbes |
New Mexico thumbs its nose at the war on drugs A panel convened by Gov. Gary Johnson calls for the legalization of marijuana and a shift in focus from penal measures to treatment for drug offenders... |
Salon.com August 2, 2001 Jared Manasek |
Smoke signal Police in London's gritty Brixton neighborhood are losing the war on drugs, so the police chief is experimenting with not enforcing cannabis laws. |
Reason November 2007 Jacob Sullum |
Spliff Split Candidates on marijuana: The U.S. House of Representatives once again rejected a measure aimed at stopping the DEA's interference with the therapeutic use of cannabis in the 12 states where it's legal. |
Reason November 2008 Jacob Sullum |
Follow State Law, Go Directly to Jail The Drug Enforcement Administration has raided more than 60 medical marijuana dispensaries in the last two years. Because the deck is stacked against them, dispensary operators facing federal drug charges typically plead guilty. |
Reason January 2006 Jacob Sullum |
That Chemo Cachet Medical marijuana and kids: Hard as it is to believe, it appears that promoting marijuana as a medicine for cancer and AIDS patients does not make it seem cooler to American teenagers. |
Reason April 2002 Jacob Sullum |
Pot Stops In the United States, it's clearly not true that no one gets arrested for smoking pot anymore. But it looks like that will soon be the case in Britain, home of Europe's harshest drug laws... |